Autopsy report · NCT01559818
A Long Term Follow up Study for Patients Who Previously Took Part in the Phase I Study IMM-101-001
Cause of deathOther
“Sponsor considered no further meaningful data was being collected, nor were likely to be collected in the future.”
Life of this trial
- Registered 1 month after it had already started.
- Ran for about 7 years 5 months before it stopped.
- 10 participants enrolled.
- Results were posted on the registry 3 years 10 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1, Phase 2
- Sponsor
- Immodulon Therapeutics Ltd
- Sponsor type
- Industry
- Conditions
- Malignant Melanoma
- Interventions
- IMM-101
- Participants
- 10
- Sites
- 1
- Countries
- United Kingdom
Trials that died the same way
- Safety, Pharmacokinetics and Antitumor Activity of BGB-B167 Alone and in Combination With Tislelizumab in Participants With Solid Tumors in Chinese Participants
“Sponsor determined the data was no longer needed.” - Comparative Mixture of Non-racemic and Racemic Enantiomers of Bupivacaine in Cesarean
“The Sponsor has no interest in continuing the study.” - ITT-5 Mechanisms of Spermatogenesis in Man
“No funding was obtained for this study.” - Manual Therapy/Exercises vs. Physiotherapy/Back School vs. Waiting List in Patients With Chronic Low Back Pain
“Sponsor did not want to continue the study.” - Robotic Versus Open Comparison in the Surgical Treatment of Wide Abdominal Wall heRnias (ROCSTAR)
“The study was not initiated and no participants were enrolled.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.